Friday, March 1, 2013

Top Stocks For 3/1/2013-4

Global Hunter Corp. (the �Company�) (TSX.V:BOB.V) engages in the acquisition, exploration, and development of mineral properties in Canada and Chile. It primarily explores for gold, copper, and base and precious metals. The company was founded in 1988 and is headquartered in Vancouver, Canada.

Global Hunter is pleased to announce that it recently completed a surface sampling program at La Corona de Cobre. The program was designed to collect surface samples from the numerous prospective shear zones. This will aid in the definition of drill targets to expand on the copper oxide mineralization. The company has collected approximately 250 samples from the shear zones listed below.

The shear zones and areas of alteration that have been sampled (from East to West) include the following zones:

- El Manto
- La Golondrina
- Cerro Borracho
- El Tazon
- La Copa
- La Varrilla
- Et Tazon
- Vino Fino
- Abisinia
- Las Posadas

The samples will be collected from outcrops along the entire strike lengths of the shears and have been shipped to ALS Chemex Labs in La Serena Chile for analysis. Results will be released as soon as is practical after they have been received.

More about (TSX.V:BOB) at: www.globalhunter.ca

RGC Resources Inc. (Nasdaq:RGCO) declared a quarterly dividend of $0.34 per share on the Company’s common stock. The indicated annual dividend is $1.36 per share, a $0.04 per share increase over the prior level. The dividend will be paid on February 1, 2010 to shareholders of record on January 14, 2011. This is the Company’s 267th consecutive quarterly cash dividend.

RGC Resources, Inc., together with its subsidiaries, operates as an energy services company.

Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN) announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every month. The primary endpoint was statistical non-inferiority in the proportion of patients who maintained (or improved) vision over 52 weeks compared to ranibizumab. Further results will be presented at the Angiogenesis Conference in February 2011. Bayer HealthCare and Regeneron are planning to submit regulatory applications for marketing approval in Europe and the U.S. in the first-half of 2011 based on the positive results of the VIEW 1 and VIEW 2 trials.

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States.

a leading international manufacturer of highly-engineered precision plain, roller and ball bearings for the industrial, defense and aerospace industries,

RBC Bearings Inc. (Nasdaq:ROLL) announced the establishment of a new $150 million 5-year senior secured revolving credit facility. The new facility replaces the existing facility which would have expired in June 2011. Terms of the facility include a $150 million revolver with an accordion option to borrow an additional $100 million under certain circumstances and with additional commitments from lenders. The facility pricing is grid based, with an initial interest rate for borrowings under the facility of LIBOR plus 150 basis points. The new credit facility will be used to fund working capital and potential acquisitions.

RBC Bearings Incorporated manufactures and markets engineered precision plain, roller, and ball bearings.

MusclePharm(R) Corporation (OTCBB:MSLP.OB), one of the fastest growing nutritional supplement companies in the United States, is pleased to announced a multi-year partnership with the World Bodybuilding and Fitness Federation (WBFF) that will place the company as the title sponsor of the World Famous WBFF through 2014.

The partnership begins in 2011 and MusclePharm will work closely with the WBFF and its President and CEO, Paul Dillett, who is widely considered one of the greatest bodybuilders in the sport’s history. Dillett, recognized as Canada’s greatest bodybuilder, won numerous bodybuilding titles throughout his illustrious career, and is often regarded as having one of the sport’s most recognizable physiques.

MSLP �s award-winning products � Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon and Shred Matrix � are also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.

MSLP�s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside. Headquartered in Aurora, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists.

More about MSLP at: www.musclepharm.com

No comments:

Post a Comment